#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
James Xue Email
Founder, chairman and CEO . CANbridge Pharmaceuticals
How to contact James Xue
Join and see James's contact info for free!Current Roles
Employees:
76Revenue:
$15.3MAbout
CANbridge Pharmaceuticals Inc. is a China-focused biopharmaceutical company accelerating development and commercialization of specialty healthcare products for orphan diseases and targeted cancers, focusing on products that are unavailable or address medical needs that are underserved in the region. CANbridge has been recognized as a leader in orphan diseases in China. It has a global partnership with WuXi Biologics to develop and commercialize proprietary therapeutics for the treatment of rare genetic diseases. In greater China, it has an exclusive licensing agreement to commercialize Hunterase®, an enzyme replacement therapy for the treatment of Hunter syndrome, developed by GC Pharma and marketed in more than ten countries worldwide. CANbridge also has an oncology portfolio, which includes exclusive rights to develop and commercialize Puma Biotechnology's NERLYNX® (neratinib), in greater China, as well as rights to other novel candidates.CANbridge Pharmaceuticals Address
4 Burlington Woods DriveCambridge, MA
United States